Table 1.
Studies Measuring Peripheral IL-6 or TNF-α in Association with Depression or Anxiety in Alzheimer’s Disease. Number of Asterisks Denote Significance Level (* P<0.05, ** P<0.01, *** P<0.001)
| Assay Source | Authors | Participants | Study Design | Scale | Inflammatory Marker | Results |
|---|---|---|---|---|---|---|
| Serum | Banerjee et al, 201789 | AD (34 with depression, 26 without depression) HC = 60 | Cross sectional case control | DSM-IV | IL-6 and TNF-α | IL-6 increased with AD with depression compared to AD without depression*** TNF-α increased in AD with depression compared to AD without depression** IL-6 (r = −0.472** and TNFα r = −0.651*** negative correlations with MMSE in AD with depression but no correlations in AD without depression. |
| Serum | Gorska-Ciebiada et al, 2015118 | MCI = 62 (25 with depression), HC = 132 (57 with depression) | Cross sectional case control | GDS | CRP, IL-6, TNF-α | GDS-30 correlated with CRP (0.56***) and TNF-α (0.77**) in MCI with depression group. Multivariate logistic regression revealed IL-6* among other factors (CVD, poor glycaemic control) increased likelihood of having MCI in depressed patients. |
| Serum | Khemka et al, 2014116 | AD = 55 (31 with depression and 24 without depression), HC = 37 | Cross sectional case control | DSV-IV criteria | IL-1-β, IL-6, TNFα | IL-6 and TNFα were higher in AD with depression compared HC and AD without depression***. Increased IL-1β in both groups of AD patients compared to controls*** |
| Serum | Johnson et al, 2016115 | AD = 107 | Cross sectional study | GDS | Inflammatory marker panel (details not described) | 7 proteins showed significantly higher risk of depression: MIP1*, IL-6 *, VCAM1*, Adiponectin*, Factor VII **, IL-5 *, ICAM1* |
| Serum and Plasma | Alvarez et al, 1996120 | AD = 20 | Cross sectional cohort | HRSD | Histamine, IL1-β, TNF-a | Negative correlation between histamine and HRSD (−0.63**) |
| Serum | Holmes et al, 201186 | AD = 275 | Longitudinal cohort study | NPI | CRP, TNF-α, IL-6 | Patients with low TNF-α had lower NPI scores over 6 months**. Increased TNF-α was associated with more frequent symptoms of agitation*, depression**, anxiety**. Lower IL-6 was associated with lower NPI scores over period of 6 months*. Increased IL-6 associated with increased frequency of hallucinations* and apathy*. |
| Serum | Hall et al, 2012117 | AD = 91, HC = 161 | Cross sectional case control | GDS | IL-6, IL-10, IL-1, CRP, TNF-α and MIF | TNF accounted for 12% variance in apathy score in men. MIF weak predictor R2 < 0.03* of total GDS score and 3/4 symptom clusters in all participants. MIF predictor of depression in men with AD accounting for 12% of the variance in apathy sore, and 15–51% of the variance in 3 symptom clusters. In females, MIF, ICAM and CRP accounted for 26% variance in apathy. |